Please check your internet connection and try again.
# Montelukast/Levocetirizine
## Overview
Montelukast is a leukotriene receptor antagonist, and levocetirizine is a second-generation antihistamine. This combination is available as a fixed-dose combination product.
## Primary Indications
* Allergic rhinitis (intermittent and perennial)
* Chronic idiopathic urticaria
## Adult Dosing
* **Allergic Rhinitis/Chronic Idiopathic Urticaria:** One tablet (montelukast 10 mg / levocetirizine 5 mg) once daily.
## Pediatric Dosing
Dosing for pediatric patients is based on age and weight, and is not available in a fixed-dose combination product for all age groups. Separate formulations of montelukast and levocetirizine are used.
* **Montelukast:**
* 1-5 years: 4 mg orally once daily.
* 6-14 years: 5 mg orally once daily.
* >= 15 years: 10 mg orally once daily.
* **Levocetirizine:**
* 6 months-5 years: 1.25 mg orally once daily.
* 6-11 years: 2.5 mg orally once daily.
* >= 12 years: 5 mg orally once daily.
## Dose Adjustments
* **Renal Impairment:**
* Levocetirizine: In adults with moderate to severe renal impairment (CrCl < 50 mL/min), the dose should be reduced. Specific dosing adjustments should be per product labeling or local protocol.
* Montelukast: No dose adjustment is typically required for renal impairment.
* **Hepatic Impairment:**
* Levocetirizine: No significant dose adjustment is usually necessary in mild hepatic impairment. Caution is advised in moderate to severe impairment.
* Montelukast: Use with caution in patients with hepatic insufficiency.
## Contraindications
* Hypersensitivity to montelukast, levocetirizine, or any component of the formulation.
* Severe renal impairment (for levocetirizine component, especially if dose adjustment is not made).
## Adverse Effects
* **Common:** Somnolence, fatigue, headache, dizziness, dry mouth, sore throat, cough, abdominal pain, diarrhea, nausea.
* **Neuropsychiatric:** Mood changes (including depression, suicidal ideation), nightmares, insomnia, hallucinations, anxiety. Montelukast carries a boxed warning for neuropsychiatric events.
* **Hypersensitivity Reactions:** Angioedema, anaphylaxis, rash, pruritus, urticaria, exfoliative dermatitis.
* **Other:** Churg-Strauss syndrome (associated with montelukast).
## Key Drug Interactions
* **CNS Depressants:** Increased sedative effects may occur with alcohol, benzodiazepines, opioids, and other sedating medications.
* **Theophylline:** Montelukast may potentially affect theophylline levels, though this is not a major concern.
* **CYP450 enzymes:** Montelukast is not expected to significantly affect the metabolism of drugs primarily metabolized by CYP enzymes. Levocetirizine is not significantly metabolized by CYP enzymes.
## Monitoring
* Monitor for signs and symptoms of neuropsychiatric effects with montelukast. Advise patients and caregivers to report any behavioral or mood changes.
* Monitor for efficacy in symptom control of allergic rhinitis or urticaria.
* Monitor for adverse effects, particularly somnolence and fatigue, especially with the levocetirizine component.
## Clinical Pearls
* While effective for allergic rhinitis and urticaria, montelukast's role in asthma management has become more limited due to concerns about neuropsychiatric side effects.
* The combination addresses both histamine-mediated symptoms (levocetirizine) and leukotriene-mediated inflammation (montelukast).
* Somnolence is a common side effect of levocetirizine; patients should be advised about potential impairment of activities requiring mental alertness.
* Always use the lowest effective dose and use caution when discontinuing montelukast, especially in patients with concurrent asthma or in whom asthma exacerbation is a consideration.
***
_This information is intended for healthcare professionals. Please consult the most current prescribing information and local protocols before making any clinical decisions. Dosing may vary based on individual patient factors and specific product formulations._
